Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Fritsch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Nuclear Medicine|August 10, 1999
Persistent segmental perfusion defect in an intermediate-probability lung scanM Gotthardt, H W Fritsch, U Welcke, et al.
Journal of the American Society for Mass Spectrometry|November 15, 2013
Gridless Ion Acceleration Systems for Time-of-Flight Mass SpectrometryL Schmidt, H Jungclas, H W Fritsch, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Limited sampling models for reliable estimation of etoposide area under the curveJ B Holz, H Köppler, L Schmidt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Pharmacokinetics of high-dose etoposide after short-term infusionP Köhl, H Köppler, L Schmidt, et al.
Clinical Nuclear Medicine|March 4, 2000
Huge necrotic liver metastases in advanced pancreatic carcinoma visualized on bone scansM Gotthardt, U Welcke, H W Fritsch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditionsK H Pflüger, M Hahn, J B Holz, et al.
Applied Clinical Informatics|January 25, 2018
Towards Implementation of OMOP in a German University Hospital ConsortiumC Maier, L Lang, H Storf, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|August 10, 1999
Persistent segmental perfusion defect in an intermediate-probability lung scanM Gotthardt, H W Fritsch, U Welcke, et al.
Journal of the American Society for Mass Spectrometry|November 15, 2013
Gridless Ion Acceleration Systems for Time-of-Flight Mass SpectrometryL Schmidt, H Jungclas, H W Fritsch, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Limited sampling models for reliable estimation of etoposide area under the curveJ B Holz, H Köppler, L Schmidt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Pharmacokinetics of high-dose etoposide after short-term infusionP Köhl, H Köppler, L Schmidt, et al.
Clinical Nuclear Medicine|March 4, 2000
Huge necrotic liver metastases in advanced pancreatic carcinoma visualized on bone scansM Gotthardt, U Welcke, H W Fritsch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditionsK H Pflüger, M Hahn, J B Holz, et al.
Applied Clinical Informatics|January 25, 2018
Towards Implementation of OMOP in a German University Hospital ConsortiumC Maier, L Lang, H Storf, et al.
Pageof 1